STOCK TITAN

Bionano Genomics Inc - BNGO STOCK NEWS

Welcome to our dedicated page for Bionano Genomics news (Ticker: BNGO), a resource for investors and traders seeking the latest updates and insights on Bionano Genomics stock.

Bionano Genomics Inc (BNGO) delivers cutting-edge optical genome mapping solutions for advanced genomic research. This news hub provides investors and researchers with essential updates on the company's innovations in structural variation analysis.

Access official press releases, financial disclosures, and technology developments in one centralized location. Track updates spanning product launches, clinical study collaborations, and peer-reviewed research validations of Bionano's OGM platform. Our curated collection ensures timely access to material developments impacting the genome analysis sector.

Key focus areas include regulatory milestones, partnership announcements, and scientific advancements demonstrating Bionano's leadership in next-generation cytogenetics. All content maintains strict factual accuracy required for informed investment decisions and research applications.

Bookmark this page for streamlined monitoring of Bionano's progress in transforming genomic medicine through high-resolution genome analysis tools. Verify critical updates directly from primary sources with our comprehensive news aggregation.

Rhea-AI Summary
Bionano Genomics announces Gülsen Kama as new CFO, effective September 11, 2023. Kama has a strong background in financial strategy and experience in managing expenses for profitable growth. She previously served as CFO at Northern Data AG and held leadership roles at Quest Diagnostics, FedEx, United Airlines, A&P, and AIG. The senior leadership team is excited to partner with Kama to propel the company to new heights.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.28%
Tags
management
-
Rhea-AI Summary
Bionano Genomics to showcase its optical genome mapping (OGM) technology at the Cancer Genomics Consortium (CGC) 2023 Annual Meeting. The company will present scientific platform and poster presentations, introduce new products, and host a panel discussion with cancer genomics experts.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.5%
Tags
none
-
Rhea-AI Summary
Bionano Genomics, Inc. reported Q2 2023 financial results with revenue of $8.7 million, a 30% increase YoY. The installed base of Saphyr® systems reached 281, a 43% increase YoY. They sold 7,062 nanochannel array flowcells, a 108% increase YoY. The company also announced new products and software releases.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.37%
Tags
Rhea-AI Summary
Bionano Genomics, Inc. (NASDAQ: BNGO) has announced a 1-for-10 reverse stock split of its common stock. The split will be effective at 5 p.m. ET on August 4, 2023, and the stock will begin trading on a split-adjusted basis on August 7, 2023. The reverse stock split will reduce the number of shares of common stock and increase the conversion and exercise prices of preferred stock, stock options, restricted stock units, and warrants. Fractional shares will be converted to cash payments. The reverse stock split will not impact stockholders' percentage ownership.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-16.95%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.92%
Tags
conferences earnings
-
Rhea-AI Summary
Bionano Genomics launches Bionano TOUR, a series of customer-led events showcasing optical genome mapping (OGM) advancements and research applications.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.72%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.08%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.41%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.23%
Tags
none
Bionano Genomics Inc

Nasdaq:BNGO

BNGO Rankings

BNGO Stock Data

12.18M
3.00M
0.11%
10.24%
18.54%
Medical Instruments & Supplies
Laboratory Analytical Instruments
Link
United States
SAN DIEGO